
Exagen XGN
$ 4.45
3.25%
Quarterly report 2026-Q1
added 05-11-2026
Exagen Depreciation & Amortization 2011-2026 | XGN
Annual Depreciation & Amortization Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1 M | 1.7 M | 2.2 M | 1.6 M | 900 K | 500 K | 600 K | 600 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.2 M | 500 K | 1.28 M |
Quarterly Depreciation & Amortization Exagen
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 600 K | 600 K | 500 K | 400 K | - | 400 K | 400 K | 500 K | - | 600 K | 500 K | 600 K | - | 400 K | 300 K | 300 K | - | 300 K | 200 K | 200 K | - | 100 K | 200 K | 100 K | - | 100 K | 200 K | 200 K | - | 200 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 600 K | 100 K | 343 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 206.0 | 0.73 % | $ 22.9 B | ||
|
Celcuity
CELC
|
167 K | $ 95.97 | 3.65 % | $ 4.49 B | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 4.46 | -0.89 % | $ 5.93 M | ||
|
Fulgent Genetics
FLGT
|
24.1 M | $ 18.75 | 1.32 % | $ 577 M | ||
|
Castle Biosciences
CSTL
|
40.8 M | $ 21.44 | 1.68 % | $ 621 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
1.4 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
383 M | $ 153.61 | 1.18 % | $ 12 B | ||
|
Guardant Health
GH
|
39.7 M | $ 132.08 | 1.5 % | $ 16.6 B | ||
|
Illumina
ILMN
|
270 M | $ 165.22 | 3.24 % | $ 25.6 B | ||
|
CareDx, Inc
CDNA
|
15 M | $ 23.03 | 1.21 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 11.61 | 1.49 % | $ 1.49 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 20.24 | 2.48 % | $ 453 M | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 100.09 | 0.11 % | $ 6.75 B | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 188.96 | -0.55 % | $ 9.37 B | ||
|
Pacific Biosciences of California
PACB
|
13 M | $ 1.41 | 2.55 % | $ 423 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 465.31 | -0.32 % | $ 13.4 B | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 159.91 | -0.26 % | $ 23.9 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.78 | 5.29 % | $ 443 M | ||
|
Natera
NTRA
|
41.8 M | $ 223.42 | 0.27 % | $ 30.5 B | ||
|
Personalis
PSNL
|
10 M | $ 10.11 | 3.64 % | $ 902 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 26.03 | -1.77 % | $ 24.7 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 7.54 | 1.41 % | $ 315 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 71.38 | 1.88 % | $ 4.27 B | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 272.06 | 0.32 % | $ 22.6 B | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 490.53 | -0.77 % | $ 185 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.35 | 0.65 % | $ 2.03 B | ||
|
Waters Corporation
WAT
|
88.1 M | $ 371.06 | -0.02 % | $ 22.1 B |